A Bioavailability Study of GS1-144 Tablets in Healthy Postmenopausal Women

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

July 14, 2025

Study Completion Date

July 14, 2025

Conditions

Healthy Postmenopausal Women

Interventions

DRUG

GS1-144 Tablet with new preparation (T)

DRUG

GS1-144 Tablet with present preparation (R)

A single oral dose of GS1-144 Tablet with present preparation

Trial Locations (1)

Chengdu Xinhua Hospital, Chengdu

All Listed Sponsors

lead

Changchun GeneScience Pharmaceutical Co., Ltd.

INDUSTRY

NCT06983925 - A Bioavailability Study of GS1-144 Tablets in Healthy Postmenopausal Women | Biotech Hunter | Biotech Hunter